Literature DB >> 16988823

Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family.

Xiao-Fei Wang1, William M Cohen, Florence A Castelli, Christine Almunia, Bernard Lethé, Sandra Pouvelle-Moratille, Gaetan Munier, Dominique Charron, André Ménez, Hassan M Zarour, Pierre van der Bruggen, Marc Busson, Bernard Maillère.   

Abstract

Because of the high frequency of HLA-DP4 in the Caucasian population, we have selectively delineated HLA-DP4 restricted T cell epitopes in the MAGE-A tumor antigens. We identified 12 good binders to HLA-DP4 and investigated the capacity of the seven best binders to induce in vitro specific CD4+ T cell lines from HLA-DP4 healthy donors. We found that the MAGE-A1 90-104 peptide exhibited a high and constant frequency of CD4+ T cell precursors in all the six tested donors. The MAGE-A1 268-282 peptide was found immunogenic in only two donors but with a high precursor frequency. The MAGE-A12 127-141 peptide was T cell stimulating in six different donors and induced fewer T cell lines. The peptide-specific T cell lines were stimulated by DC loaded with the lysates of cells transfected with MAGE-A1 or MAGE-A12, or loaded with the recombinant protein. We also show that the immunoreactivity of CD4+ T cell epitopes restricted to the same HLA II molecule may vary from one individual to another, as a result of inter-individual variations in the CD4+ T cell repertoire.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988823     DOI: 10.1007/s00262-006-0230-y

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  7 in total

1.  Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.

Authors:  Carla Oseroff; Bjoern Peters; Valerie Pasquetto; Magdalini Moutaftsi; John Sidney; Vijay Panchanathan; David C Tscharke; Bernard Maillere; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

2.  Automated benchmarking of peptide-MHC class I binding predictions.

Authors:  Thomas Trolle; Imir G Metushi; Jason A Greenbaum; Yohan Kim; John Sidney; Ole Lund; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Bioinformatics       Date:  2015-02-25       Impact factor: 6.937

3.  The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.

Authors:  Jerome Kerzerho; Aurélie Schneider; Emmanuel Favry; Florence Anne Castelli; Bernard Maillère
Journal:  J Biol Chem       Date:  2013-04-03       Impact factor: 5.157

4.  Evolutionary history of the cancer immunity antigen MAGE gene family.

Authors:  Yukako Katsura; Yoko Satta
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

5.  Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein.

Authors:  Zhitao Ru; Wenjun Xiao; Anthony Pajot; Zhihua Kou; Shihui Sun; Bernard Maillere; Guangyu Zhao; David M Ojcius; Yu-Chun Lone; Yusen Zhou
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 6.  Cancer testis antigen and immunotherapy.

Authors:  Deepa Kolaseri Krishnadas; Fanqi Bai; Kenneth G Lucas
Journal:  Immunotargets Ther       Date:  2013-04-17

Review 7.  Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.

Authors:  Neftali Ortega Alarcon; Maddy Jaramillo; Heidi M Mansour; Bo Sun
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.